Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.


Ebola drug tests offer ‘hope’

02 March 2015, 07:08

Tokyo -The Japanese company behind an experimental Ebola treatment says it offers new hope for thousands of people infected with the deadly virus in west Africa, but acknowledged it is "not a miracle drug".

In their first comments to media since the release of early clinical trials last week, executives from Fujifilm's drug unit Toyama Chemical said the results were a "good first step" that could lead to larger and better-designed trials.

Avigan - approved for use in Japan as an influenza treatment - was somewhat effective at saving the lives of Ebola patients if given early in the illness, but not later, according to the results presented to a US conference.

"They were better than my expectations," Fujifilm director Yuzo Toda said in an interview at the company's office in Tokyo.

"Taking this medicine as early as possible [means] the mortality rate can be significantly reduced. That sends a very strong message to the patient."

Testing began late last year, led by Inserm, the French Institute of Health and Medical Research, and is being funded by the European Commission.

The ongoing clinical trial in hard-hit Guinea - dubbed Jiki, meaning hope in the local language - is testing the drug on patients with Ebola, which causes severe vomiting, diarrhoea and sometimes fatal bleeding.

Results from only 80 people are available so far, but they show that among those who received the drug early in their illness, 15% died.

However, among those who received it when their viral load was high, 93% died, according to the preliminary results presented at the Conference on Retroviruses and Opportunistic Infections in Seattle, Washington.

No help for most vulnerable

There are no drugs on the market to treat Ebola, which has ravaged west Africa and killed 9 177 of the nearly 23 000 people infected since late 2013. Clinical trials of other experimental drugs are under way but are at an earlier stage.

The death rate from the virus in the latest outbreak has ranged from 53 to 60%, according to the World Health Organisation.

Also read: Obasanjo visits Ebola-hit countries

NGO Medecins Sans Frontieres (Doctors Without Borders), which is among those helping to carry out the trial, said it was happy to see the drug "seems to have a positive effect for certain patients".

"But it also seems that the most vulnerable patients, the people that are most likely to die from the disease, don't benefit at all," said the group's medical director Bertrand Draguez.


Toda and his colleagues acknowledged the drug's apparent limitations, but said any positive results could help spread the word among the worst-hit communities and convince more patients to sign up for clinical trials.

They hope the WHO will accelerate the use of Avigan to deal with the Ebola crisis.

"We didn't expect it would work for all patients, or be a miracle drug, but this is a very good first step," said Hiroshi Kitaguchi, general manager of the business development unit at Toyama Chemical, which developed Avigan.

"The results may not be a miracle, but we can say it is a miracle that we have [come] this far in such a short period of time."

Best known for its photo film and camera business, Fujifilm started to acquire healthcare firms nearly a decade ago in a bid to branch into other sectors as demand for camera film plummeted. Among them was Toyama Chemical, which it bought in 2008.



Read News24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Read more from our Users

Nigeria @ 56: Words to my green f...

A leader’s job is not to dictate, but rather to be respected, admired and be a trustee, of the land we love, with so much potential, a land which should be freer than free. Its still a long way to fufilling our destiny! Read more...

Submitted by
Isaac Asabor263
Recession: An opportunity for Nig...

The recession should be seen as an opportunity for the country’s promotion as long as we all collectively conduct ourselves in a patriotic manner, writes Isaac Asabor.  Read more...

Submitted by
Black and White

We want to imitate the whites in everything because we are ignorant of our inherent originality and content. We spend all our Naira to acquire his inventions because we so oblivious of our natural endowments that we allow him have it for free. Read more...

Submitted by
Nate Nat
Adamawa State University Mubi: A ...

ADSU integrity forum has accused the Sunday Joshua Wugira, a lawyer, of adopting unorthodox tactics by abusing his privilege by attacking the integrity of ADSU Vice Chancellor Dr. Moses Zira Zaruwa, writes a News24 reader. Read more...

Submitted by
Abdulsalam Jubril
My Country Nigeria (Part One)

Poetry by Abdulsalam Jubril.

Submitted by
Abdulsalam Jubril
Recession, dearth in leadership a...

Every leader has the opportunity to become great and making himself immortal in the lives and hearts of people for generations to come. Will Mr. President seize this opportunity?, questions Abdulsalam Jubril. Read more...